2023 updated MASCC/ESMO consensus recommendations: controlling nausea and vomiting with chemotherapy of low or minimal emetic potential.
Ian N OlverRebecca Clark-SnowChristina Halgaard Bruvik RuhlmannMaria-Angeles Garcia-Del-BarrioFlorian ScottéBernardo Leon RapoportFranziska JahnPublished in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2023)
There is insufficient data to change the current guidelines. Future studies should seek to more accurately determine the risk of emesis with LEC beyond the emetogenicity of the chemotherapy to include patient-related risk assessment.